Related Experiment Video
Updated: Mar 17, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN
Maurizio Salvadori1, Giuseppina Rosso1
1Maurizio Salvadori, Department of Renal Transplantation, Careggi University Hospital, 50139 Florence, Italy.
Abstract:
This review revises the reclassification of the membranoproliferative glomerulonephritis (MPGN) after the consensus conference that by 2015 reclassified all the glomerulonephritis basing on etiology and pathogenesis, instead of the histomorphological aspects. After reclassification, two types of MPGN are to date recognized: The immunocomplexes mediated MPGN and the complement mediated MPGN. The latter type is more extensively described in the review either because several of these entities are completely new or because the improved knowledge of the complement cascade allowed for new diagnostic and therapeutic approaches. Overall the complement mediated MPGN are related to acquired or genetic cause. The presence of circulating auto antibodies is the principal acquired cause. Genetic wide association studies and family studies allowed to recognize genetic mutations of different types as causes of the complement dysregulation. The complement cascade is a complex phenomenon and activating factors and regulating factors should be distinguished. Genetic mutations causing abnormalities either in activating or in regulating factors have been described. The diagnosis of the complement mediated MPGN requires a complete study of all these different complement factors. As a consequence, new therapeutic approaches are becoming available. Indeed, in addition to a nonspecific treatment and to the immunosuppression that has the aim to block the auto antibodies production, the specific inhibition of complement activation is relatively new and may act either blocking the C5 convertase or the C3 convertase. The drugs acting on C3 convertase are still in different phases of clinical development and might represent drugs for the future. Overall the authors consider that one of the principal problems in finding new types of drugs are both the rarity of the disease and the consequent poor interest in the marketing and the lack of large international cooperative studies.
Insights
Membranoproliferative glomerulonephritis (MPGN) is now classified into immune complex-mediated and complement-mediated types. Complement-mediated MPGN, often caused by genetic or acquired factors, presents new diagnostic and therapeutic opportunities.
Area of Science:
- Nephrology
- Immunology
- Genetics
Background:
- Membranoproliferative glomerulonephritis (MPGN) reclassification shifted focus from histomorphology to etiology and pathogenesis.
- Two main types of MPGN are now recognized: immune complex-mediated and complement-mediated.
Purpose of the Study:
- To review the reclassification of MPGN.
- To extensively describe complement-mediated MPGN, including its causes and new therapeutic strategies.
Main Methods:
- Review of literature following the 2015 MPGN consensus conference.
- Analysis of acquired and genetic causes of complement dysregulation in MPGN.
- Evaluation of diagnostic approaches and emerging therapeutic targets in the complement cascade.
Main Results:
- Complement-mediated MPGN encompasses novel entities and is linked to acquired (autoantibodies) or genetic causes.
- Understanding complement cascade factors is crucial for diagnosis.
- Specific inhibition of complement activation (C5 or C3 convertase) represents a new therapeutic avenue.
Conclusions:
- Complement-mediated MPGN requires comprehensive diagnostic evaluation of complement factors.
- Targeted complement inhibition offers promising future therapies.
- Disease rarity and lack of cooperative studies hinder drug development for MPGN.
More Related Videos
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease III: Interprofessional Care
Hypersensitivity Reactions: Immune-Complex Reactions
Nephrotic Syndrome II : Assessment and Medical Management
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...